D-galactose induces senescence of glioblastoma cells through YAP-CDK6 pathway.
Ontology highlight
ABSTRACT: Treatment of glioblastoma using radiotherapy and chemotherapy has various outcomes, key among them being cellular senescence. However, the molecular mechanisms of this process remain unclear. In the present study, we tested the ability of D-galactose (D-gal), a reducing sugar, to induce senescence in glioblastoma cells. Following pretreatment with D-gal, glioblastoma cell lines (C6 and U87MG) showed typical characteristics of senescence. These included the reduced cell proliferation, hypertrophic morphology, increased senescence-associated β-galactosidase activity, downregulation of Lamin B1, and upregulation of several senescence-associated genes such as p16, p53, and NF-κB. Furthermore, our results showed that D-gal was more suitable than etoposide (a DNA-damage drug) in inducing senesce
SUBMITTER: Xu X
PROVIDER: S-EPMC7585072 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA